missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ CXCL9/MIG Antibody (Novimmune patent anti-CXCL9) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Marca: Novus Biologicals™ NBP3-28413-100ug
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
CXCL9/MIG Monoclonal antibody specifically detects CXCL9/MIG in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifica
| CXCL9/MIG | |
| Monoclonal | |
| Unconjugated | |
| Q07325 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| Novimmune patent anti-CXCL9 | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| chemokine (C-X-C motif) ligand 9, CMK, crg-10, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Humig, MIGSmall-inducible cytokine B9, monokine induced by gamma interferon, SCYB9Monokine induced by interferon-gamma | |
| CXCL9 | |
| 100 μg | |
| Biologically Active Proteins, Chemokines and Cytokines, Signal Transduction | |
| 4283 | |
| Human | |
| Purified |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto